Page last updated: 2024-08-24

nafagrel and Acute Promyelocytic Leukemia

nafagrel has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Homma, M; Ichikawa, Y; Kameda, H; Yoshida, T	1

Other Studies

1 other study(ies) available for nafagrel and Acute Promyelocytic Leukemia

Article	Year
Thromboxane A2 synthase inhibitor, DP-1904, decreases TNF alpha secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial cell surfaces. Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23 Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Line; Cell Membrane; Cells, Cultured; E-Selectin; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Intercellular Adhesion Molecule-1; Leukemia, Promyelocytic, Acute; Monocytes; Tetrahydronaphthalenes; Thromboxane-A Synthase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins	1995

Article

Year

Thromboxane A2 synthase inhibitor, DP-1904, decreases TNF alpha secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial cell surfaces.

Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

Topics: Cell Adhesion; Cell Adhesion Molecules; Cell Line; Cell Membrane; Cells, Cultured; E-Selectin; Endothelium, Vascular; Humans; Imidazoles; In Vitro Techniques; Intercellular Adhesion Molecule-1; Leukemia, Promyelocytic, Acute; Monocytes; Tetrahydronaphthalenes; Thromboxane-A Synthase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins

1995